Compare ATCH & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATCH | COSM |
|---|---|---|
| Founded | 2022 | 2009 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6M | 33.8M |
| IPO Year | 2024 | 2009 |
| Metric | ATCH | COSM |
|---|---|---|
| Price | $0.16 | $0.33 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 3.4M |
| Earning Date | 11-13-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.15 |
| EPS | ★ 0.02 | N/A |
| Revenue | $20,052,635.00 | ★ $65,271,815.00 |
| Revenue This Year | $32.20 | $23.79 |
| Revenue Next Year | N/A | $58.42 |
| P/E Ratio | $8.18 | ★ N/A |
| Revenue Growth | ★ 84.70 | 19.93 |
| 52 Week Low | $0.16 | $0.16 |
| 52 Week High | $0.54 | $1.07 |
| Indicator | ATCH | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 49.67 |
| Support Level | N/A | $0.29 |
| Resistance Level | $0.21 | $0.35 |
| Average True Range (ATR) | 0.01 | 0.04 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 6.27 | 27.73 |
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.